Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

LaCell LLC
Profile last edited on: 8/18/20      CAGE: 5Y7M2      UEI: XLSJJDZ6LYA5

Business Identifier: production of premium quality stromal / stem cells
Year Founded
2010
First Award
2012
Latest Award
2019
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1441 Canal Street Suite 304
Baton Rouge, LA 70112
   (504) 598-5246
   contact@lacell-usa.com
   lacell.wpengine.com
Location: Single
Congr. District: 02
County: Orleans Parish

Public Profile

LaCell focuses on the production of premium quality stromal/stem cells for scientific investigators in the academic and biotechnology research community. Their long term goal is to facilitate the clinical translation and regulatory approval or stromal/stem cells as regenerative therapies.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$646,423
Phase II Dollars
$1,227,530
Total Awarded
$1,873,953

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 1 NIH $235,464
Project Title: Universal Media For Maintenance Of Mesodermal Lineage Mps Systems
2017 2 NIH $1,413,489
Project Title: Adipose-Derived Stromal/Stem Cell Therapy for Pressure Ulcers
2016 1 NSF $225,000
Project Title: Tissue Engineered Human "Fat-on-a-Chip"- a Novel Tool for Metabolic Drug Discovery

Key People / Management

  Jeffrey Gimble -- Co-Founder & Chief Scientific Officer

  Forum Shah -- R&D Project Engineer

  Xiying Wu -- Co-Founder & Director of Research & Development

Company News

Jan 01 2013
Adipose-derived stromal/stem cells: a primer.